![Charles Rudin](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/node/24712/3x2/rudin-charles_210513_007-custom-crop.jpg?h=cd2a7045)
Charles M. Rudin, MD, PhD
Thoracic Medical Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Lung Cancer and Other Thoracic Malignancies
- Developmental Therapies
Request an Appointment
About Me
- Cancer Center Deputy Director
- Chief, Thoracic Oncology Service
- Co-Director, Druckenmiller Center for Lung Cancer Research
- Sylvia Hassenfeld Chair in Lung Cancer Research
I am a board-certified medical oncologist specializing in the care of patients with lung cancer.
In addition to serving as Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center, I have led the National Cancer Institute’s Small Cell Lung Cancer Research Consortium since its inception in 2015.
Read more
I direct a broad research program of therapeutic research with the ultimate goal of improving the outcome for patients with lung cancer. My research includes laboratory-based investigations to identify and test novel treatment approaches to lung cancer, early-phase clinical trials to bring these ideas to the clinic, and later-phase studies to establish the efficacy of these new approaches.
A thoracic oncologist is a cancer doctor with special training in thoracic (thor-A-sik) cancers. These are cancers that have to do with the chest, including lung, tracheal (windpipe), and thymic (thymus) cancers.
My Specialties
- Lung Cancer and Other Thoracic Malignancies
- Developmental Therapies
Education
- MD, PhD, University of Chicago Pritzker School of Medicine
Residencies
- University of Chicago Medical Center
Awards and Honors
- Castle Connolly: America’s Top Doctor (2024)
- Top Doctors New York Metro Area, Castle Connolly (2023)
- Castle Connolly: America's Top Doctors (2023)
- Outstanding Investigator Award, National Cancer Institute
- Director's Service Award, National Cancer Institute
- Paul Bunn Lifetime Achievement Award, International Association for the Study of Lung Cancer
- Association of American Physicians
Fellowships
- University of Chicago Medical Center
Board Certifications
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
![Women talking](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/paragraph/131881/cta_image/app-220128-006_rt_1200x800.jpeg?h=10d202d3)
New Patients
Current Patients
Contact and Location
Dr. Rudin sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Rudin
- A Phase II Study of DS-7300a in People with Previously Treated Extensive Stage Small Cell Lung Cancer
- Clinical Trials Co-Investigated by Dr. Rudin
- A Phase I/II Study of HPN328 Immunotherapy in People with Cancer That Makes the DLL3 Protein
- A Phase III Study of Pembrolizumab Immunotherapy plus Concurrent Chemoradiation Therapy Followed by Pembrolizumab with or without Olaparib, Compared to Concurrent Chemoradiation Therapy Alone in People with Newly Diagnosed Untreated Limited-Stage Small…
![Smiling doctors in the lab](/themes/mskcc/images/clinicaltrials_small.png)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Rudin’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Charles M. Rudin discloses the following relationships and financial interests:
-
AbbVie
Professional Services and Activities -
Amgen
Professional Services and Activities -
Boehringer Ingelheim
Professional Services and Activities -
D2G Oncology
Professional Services and Activities -
Daiichi Sankyo
Intellectual Property Rights -
Earli Inc.
Equity
-
Harpoon Therapeutics, Inc.
Professional Services and Activities -
Jazz Pharmaceuticals
Professional Services and Activities -
Mariana Oncology, Inc.
Professional Services and Activities -
Scorpion Therapeutics, Inc.
Professional Services and Activities -
Treeline Biosciences, Inc.
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].